関節痛治療のグローバル市場2023:NSAID、コルチコステロイド、抗うつ薬、抗けいれん薬、抗生物質

■ 英語タイトル:Global Arthralgia Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR23AG11620)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR23AG11620
■ 発行日:2023年8月
■ 調査対象地域:グローバル
■ 産業分野:医薬品&ヘルスケア
■ ページ数:104
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[関節痛治療のグローバル市場2023:NSAID、コルチコステロイド、抗うつ薬、抗けいれん薬、抗生物質]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Global Info Research社の最新の調査によると、関節痛治療のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の関節痛治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 関節痛治療の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

関節痛治療市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・NSAID、コルチコステロイド、抗うつ薬、抗けいれん薬、抗生物質

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・Pfizer Inc.、GSK Plc、Novartis AG、Mylan N.V.、Teva Pharmaceutical Industries Ltd.、Sanofi S.A、Boehringer Ingelheim International GmbH、AstraZeneca、Johnson & Johnson Private Limited、Merck & Co., Inc.、Hoffmann-La Roche Ltd.、Bristol-Myers Squibb Company

地域別セグメントは次の地域・国をカバーします。
・北米(アメリカ、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、関節痛治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な関節痛治療メーカーの企業概要、2019年~2022年までの関節痛治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な関節痛治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別関節痛治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの関節痛治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での関節痛治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および関節痛治療の産業チェーンを掲載しています。
・第14、15章では、関節痛治療の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 関節痛治療の概要
– 種類別分析(2018年vs2022年vs2029年):NSAID、コルチコステロイド、抗うつ薬、抗けいれん薬、抗生物質
– 用途別分析(2018年vs2022年vs2029年):病院薬局、小売薬局、オンライン薬局
– 世界の関節痛治療市場規模・予測
– 世界の関節痛治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Pfizer Inc.、GSK Plc、Novartis AG、Mylan N.V.、Teva Pharmaceutical Industries Ltd.、Sanofi S.A、Boehringer Ingelheim International GmbH、AstraZeneca、Johnson & Johnson Private Limited、Merck & Co., Inc.、Hoffmann-La Roche Ltd.、Bristol-Myers Squibb Company
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:NSAID、コルチコステロイド、抗うつ薬、抗けいれん薬、抗生物質
・用途別分析2018年-2029年:病院薬局、小売薬局、オンライン薬局
・関節痛治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・関節痛治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・関節痛治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・関節痛治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・関節痛治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1 Market Overview
1.1 Product Overview and Scope of Arthralgia Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Arthralgia Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 NSAID
1.3.3 Corticosteroids
1.3.4 Antidepressants
1.3.5 Anticonvulsants
1.3.6 Antibiotics
1.4 Market Analysis by Application
1.4.1 Overview: Global Arthralgia Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Arthralgia Treatment Market Size & Forecast
1.5.1 Global Arthralgia Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Arthralgia Treatment Sales Quantity (2018-2029)
1.5.3 Global Arthralgia Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Arthralgia Treatment Product and Services
2.1.4 Pfizer Inc. Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 GSK Plc
2.2.1 GSK Plc Details
2.2.2 GSK Plc Major Business
2.2.3 GSK Plc Arthralgia Treatment Product and Services
2.2.4 GSK Plc Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Plc Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Arthralgia Treatment Product and Services
2.3.4 Novartis AG Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Mylan N.V.
2.4.1 Mylan N.V. Details
2.4.2 Mylan N.V. Major Business
2.4.3 Mylan N.V. Arthralgia Treatment Product and Services
2.4.4 Mylan N.V. Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan N.V. Recent Developments/Updates
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
2.5.3 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product and Services
2.5.4 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.6 Sanofi S.A
2.6.1 Sanofi S.A Details
2.6.2 Sanofi S.A Major Business
2.6.3 Sanofi S.A Arthralgia Treatment Product and Services
2.6.4 Sanofi S.A Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi S.A Recent Developments/Updates
2.7 Boehringer Ingelheim International GmbH
2.7.1 Boehringer Ingelheim International GmbH Details
2.7.2 Boehringer Ingelheim International GmbH Major Business
2.7.3 Boehringer Ingelheim International GmbH Arthralgia Treatment Product and Services
2.7.4 Boehringer Ingelheim International GmbH Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Arthralgia Treatment Product and Services
2.8.4 AstraZeneca Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Johnson & Johnson Private Limited
2.9.1 Johnson & Johnson Private Limited Details
2.9.2 Johnson & Johnson Private Limited Major Business
2.9.3 Johnson & Johnson Private Limited Arthralgia Treatment Product and Services
2.9.4 Johnson & Johnson Private Limited Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Johnson & Johnson Private Limited Recent Developments/Updates
2.10 Merck & Co., Inc.
2.10.1 Merck & Co., Inc. Details
2.10.2 Merck & Co., Inc. Major Business
2.10.3 Merck & Co., Inc. Arthralgia Treatment Product and Services
2.10.4 Merck & Co., Inc. Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck & Co., Inc. Recent Developments/Updates
2.11 Hoffmann-La Roche Ltd.
2.11.1 Hoffmann-La Roche Ltd. Details
2.11.2 Hoffmann-La Roche Ltd. Major Business
2.11.3 Hoffmann-La Roche Ltd. Arthralgia Treatment Product and Services
2.11.4 Hoffmann-La Roche Ltd. Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
2.12 Bristol-Myers Squibb Company
2.12.1 Bristol-Myers Squibb Company Details
2.12.2 Bristol-Myers Squibb Company Major Business
2.12.3 Bristol-Myers Squibb Company Arthralgia Treatment Product and Services
2.12.4 Bristol-Myers Squibb Company Arthralgia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bristol-Myers Squibb Company Recent Developments/Updates
3 Competitive Environment: Arthralgia Treatment by Manufacturer
3.1 Global Arthralgia Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Arthralgia Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Arthralgia Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Arthralgia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Arthralgia Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Arthralgia Treatment Manufacturer Market Share in 2022
3.5 Arthralgia Treatment Market: Overall Company Footprint Analysis
3.5.1 Arthralgia Treatment Market: Region Footprint
3.5.2 Arthralgia Treatment Market: Company Product Type Footprint
3.5.3 Arthralgia Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Arthralgia Treatment Market Size by Region
4.1.1 Global Arthralgia Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Arthralgia Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Arthralgia Treatment Average Price by Region (2018-2029)
4.2 North America Arthralgia Treatment Consumption Value (2018-2029)
4.3 Europe Arthralgia Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Arthralgia Treatment Consumption Value (2018-2029)
4.5 South America Arthralgia Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Arthralgia Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Arthralgia Treatment Sales Quantity by Type (2018-2029)
5.2 Global Arthralgia Treatment Consumption Value by Type (2018-2029)
5.3 Global Arthralgia Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Arthralgia Treatment Sales Quantity by Application (2018-2029)
6.2 Global Arthralgia Treatment Consumption Value by Application (2018-2029)
6.3 Global Arthralgia Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Arthralgia Treatment Sales Quantity by Type (2018-2029)
7.2 North America Arthralgia Treatment Sales Quantity by Application (2018-2029)
7.3 North America Arthralgia Treatment Market Size by Country
7.3.1 North America Arthralgia Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Arthralgia Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Arthralgia Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Arthralgia Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Arthralgia Treatment Market Size by Country
8.3.1 Europe Arthralgia Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Arthralgia Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Arthralgia Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Arthralgia Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Arthralgia Treatment Market Size by Region
9.3.1 Asia-Pacific Arthralgia Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Arthralgia Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Arthralgia Treatment Sales Quantity by Type (2018-2029)
10.2 South America Arthralgia Treatment Sales Quantity by Application (2018-2029)
10.3 South America Arthralgia Treatment Market Size by Country
10.3.1 South America Arthralgia Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Arthralgia Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Arthralgia Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Arthralgia Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Arthralgia Treatment Market Size by Country
11.3.1 Middle East & Africa Arthralgia Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Arthralgia Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Arthralgia Treatment Market Drivers
12.2 Arthralgia Treatment Market Restraints
12.3 Arthralgia Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Arthralgia Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Arthralgia Treatment
13.3 Arthralgia Treatment Production Process
13.4 Arthralgia Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Arthralgia Treatment Typical Distributors
14.3 Arthralgia Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Arthralgia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Arthralgia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Arthralgia Treatment Product and Services
Table 6. Pfizer Inc. Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 9. GSK Plc Major Business
Table 10. GSK Plc Arthralgia Treatment Product and Services
Table 11. GSK Plc Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Plc Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Arthralgia Treatment Product and Services
Table 16. Novartis AG Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 19. Mylan N.V. Major Business
Table 20. Mylan N.V. Arthralgia Treatment Product and Services
Table 21. Mylan N.V. Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan N.V. Recent Developments/Updates
Table 23. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd. Major Business
Table 25. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product and Services
Table 26. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 28. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi S.A Major Business
Table 30. Sanofi S.A Arthralgia Treatment Product and Services
Table 31. Sanofi S.A Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanofi S.A Recent Developments/Updates
Table 33. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 34. Boehringer Ingelheim International GmbH Major Business
Table 35. Boehringer Ingelheim International GmbH Arthralgia Treatment Product and Services
Table 36. Boehringer Ingelheim International GmbH Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Arthralgia Treatment Product and Services
Table 41. AstraZeneca Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Johnson & Johnson Private Limited Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Private Limited Major Business
Table 45. Johnson & Johnson Private Limited Arthralgia Treatment Product and Services
Table 46. Johnson & Johnson Private Limited Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Johnson & Johnson Private Limited Recent Developments/Updates
Table 48. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Merck & Co., Inc. Major Business
Table 50. Merck & Co., Inc. Arthralgia Treatment Product and Services
Table 51. Merck & Co., Inc. Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck & Co., Inc. Recent Developments/Updates
Table 53. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Hoffmann-La Roche Ltd. Major Business
Table 55. Hoffmann-La Roche Ltd. Arthralgia Treatment Product and Services
Table 56. Hoffmann-La Roche Ltd. Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 58. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 59. Bristol-Myers Squibb Company Major Business
Table 60. Bristol-Myers Squibb Company Arthralgia Treatment Product and Services
Table 61. Bristol-Myers Squibb Company Arthralgia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Bristol-Myers Squibb Company Recent Developments/Updates
Table 63. Global Arthralgia Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Arthralgia Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Arthralgia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Arthralgia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Arthralgia Treatment Production Site of Key Manufacturer
Table 68. Arthralgia Treatment Market: Company Product Type Footprint
Table 69. Arthralgia Treatment Market: Company Product Application Footprint
Table 70. Arthralgia Treatment New Market Entrants and Barriers to Market Entry
Table 71. Arthralgia Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Arthralgia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Arthralgia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Arthralgia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Arthralgia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Arthralgia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Arthralgia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Arthralgia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Arthralgia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Arthralgia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Arthralgia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Arthralgia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Arthralgia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Arthralgia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Arthralgia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Arthralgia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Arthralgia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Arthralgia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Arthralgia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Arthralgia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Arthralgia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Arthralgia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Arthralgia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Arthralgia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Arthralgia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Arthralgia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Arthralgia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Arthralgia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Arthralgia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Arthralgia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Arthralgia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Arthralgia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Arthralgia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Arthralgia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Arthralgia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Arthralgia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Arthralgia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Arthralgia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Arthralgia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Arthralgia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Arthralgia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Arthralgia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Arthralgia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Arthralgia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Arthralgia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Arthralgia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Arthralgia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Arthralgia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Arthralgia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Arthralgia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Arthralgia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Arthralgia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Arthralgia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Arthralgia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Arthralgia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Arthralgia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Arthralgia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Arthralgia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Arthralgia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Arthralgia Treatment Raw Material
Table 131. Key Manufacturers of Arthralgia Treatment Raw Materials
Table 132. Arthralgia Treatment Typical Distributors
Table 133. Arthralgia Treatment Typical Customers
List of Figures
Figure 1. Arthralgia Treatment Picture
Figure 2. Global Arthralgia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Arthralgia Treatment Consumption Value Market Share by Type in 2022
Figure 4. NSAID Examples
Figure 5. Corticosteroids Examples
Figure 6. Antidepressants Examples
Figure 7. Anticonvulsants Examples
Figure 8. Antibiotics Examples
Figure 9. Global Arthralgia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Arthralgia Treatment Consumption Value Market Share by Application in 2022
Figure 11. Hospital Pharmacy Examples
Figure 12. Retail Pharmacy Examples
Figure 13. Online Pharmacy Examples
Figure 14. Global Arthralgia Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Arthralgia Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Arthralgia Treatment Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Arthralgia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Arthralgia Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Arthralgia Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Arthralgia Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Arthralgia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Arthralgia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Arthralgia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Arthralgia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Arthralgia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Arthralgia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Arthralgia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Arthralgia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Arthralgia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Arthralgia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Arthralgia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Arthralgia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Arthralgia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Arthralgia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Arthralgia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Arthralgia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Arthralgia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Arthralgia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Arthralgia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Arthralgia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Arthralgia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Arthralgia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Arthralgia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Arthralgia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Arthralgia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Arthralgia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Arthralgia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 56. China Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Arthralgia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Arthralgia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Arthralgia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Arthralgia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Arthralgia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Arthralgia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Arthralgia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Arthralgia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Arthralgia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Arthralgia Treatment Market Drivers
Figure 77. Arthralgia Treatment Market Restraints
Figure 78. Arthralgia Treatment Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Arthralgia Treatment in 2022
Figure 81. Manufacturing Process Analysis of Arthralgia Treatment
Figure 82. Arthralgia Treatment Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR23AG11620 )"関節痛治療のグローバル市場2023:NSAID、コルチコステロイド、抗うつ薬、抗けいれん薬、抗生物質" (英文:Global Arthralgia Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。